Upload
lyanh
View
215
Download
0
Embed Size (px)
Citation preview
PATIENTS WITH POLYPHARMACYThe importance of closing the loop at care transitions
Marjolein Weda, RIVM
Polypharmacy
Various definitions available.
In the Netherlands: the chronic use of 5 or more medicines.
Polypharmacie: ca. 45% of the elderly (≥ 65 years)
About 20% of people older than 70 years: 10 or more medicinal products
11/6/2014 © 2012–2014 Healthcare Information and Management Systems Society (HIMSS) 2
Polypharmacy (continued)Most older people live at home, without formal care.
More than 200.000 elderly live at:
• home, with care/nursing;
• care homes;
• nursing homes;
• mental care homes.
11/6/2014 © 2012–2014 Healthcare Information and Management Systems Society (HIMSS) 3
Polypharmacy (continued)
Polypharmacy is a risk factor for avoidable, unplanned hospitalizations.
11/6/2014 © 2012–2014 Healthcare Information and Management Systems Society (HIMSS) 4
Problems experiencedMedication related problems:
• Overuse
• Underus
• Interactions
• Double medication
• Incorrect dose
• Non-suitable dosage form
11/6/2014 © 2012–2014 Healthcare Information and Management Systems Society (HIMSS) 5
Problems experienced (continued)Risk factors:
• Decreased cognition;
• Age;
• Decreased kidney functioning;
• Not living at home (dependent on care);
• Non-adherence;
• Specific medicine classes;
• Knowledge of prescribers/pharmacists;
• Number of prescribers.
11/6/2014 © 2012–2014 Healthcare Information and Management Systems Society (HIMSS) 6
Problems experienced (continued)Many actors involved with the care for patients with polypharmacy:
• General practitioners;
• Medical specialists from various disciplines;
• Nurses;
• Pharmacists;
• Paramedical professionals;
• Mental care professionals;
• Informal caregivers.
11/6/2014 © 2012–2014 Healthcare Information and Management Systems Society (HIMSS) 7
Problems experienced (continued)Several steps in the pharmaceutical care process:
11/6/2014 © 2012–2014 Healthcare Information and Management Systems Society (HIMSS) 8
Prescribing Dispensing Using Monitoring
These steps take place at various settings, by various professionals, at various moments in time.
Detection of problemsMany systems available at different settings:
• Electronic prescription system at general practioner;
• Community pharmacy information system;
• (Electronic) prescription system at hospitals;
• Hospital pharmacy information system;
• (Electronic) prescription system at nursing homes;
• Electronic patient care dossier;
• ……….
Numerous commercial & non-commercial parties involved in setting up and maintaining these systems.
11/6/2014 © 2012–2014 Healthcare Information and Management Systems Society (HIMSS) 9
Detection of problems (continued)Vigilance of drug-drug interactions, drug-disease interactions, contra-indications, correct dosing, underuse, overuse, dubble medication.
Vigilance only work well when all information on patient and medication is available at all time points in the pharmaceutical care process (up-to-date medication history, indications, laboratory values, etcetera).
11/6/2014 © 2012–2014 Healthcare Information and Management Systems Society (HIMSS) 10
Problems experienced in practiceNo adequate communication between professionals;
No adequate communication between patient and professional;
No up-to-date medication history available, during transitions in care;
Not always time to reconcile medicinal products used by patients (urgent care);
Unclear who is directing/responsible;
ICT systems not sufficiently facilitating.
11/6/2014 © 2012–2014 Healthcare Information and Management Systems Society (HIMSS) 11
What is happening in practice?
11/6/2014 © 2012–2014 Healthcare Information and Management Systems Society (HIMSS) 12
THANK YOU FOR YOUR ATTENTION
HTTP://WWW.RIVM.NL/DOCUMENTEN_EN_PUBLICATIES/WETENSCHAPPELIJK/RAPPORTEN/2013/JULI/POLYFARMACIE_BIJ_KWETSBARE_OUDEREN_INVENTARISATIE_VAN_RISICO_S_EN_MOGELIJKE_INTERVENTIESTRATEGIE%C3%ABN
Any questions? Feel free to ask.
11/6/2014 © 2012–2014 Healthcare Information and Management Systems Society (HIMSS) 13